budesonide / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 20 Diseases   17 Trials   17 Trials   3666 News 


«12...2526272829303132333435...4243»
  • ||||||||||  budesonide / Generic mfg.
    Clinical, Review, Journal:  Eosinophilic esophagitis in children: doubts and future perspectives. (Pubmed Central) -  Jun 26, 2020   
    We speculate that combined biological therapies targeting more than one molecule or cell may provide better results, with conventional therapies potentially enhancing the effects of antibodies. However, further studies should aim to find the best therapeutic approach to target the cells involved in the remodelling process and to reverse the histological changes in this complex clinical condition.
  • ||||||||||  Preclinical, Journal:  An Exploration of Factors Affecting In Vitro Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat. (Pubmed Central) -  Jun 26, 2020   
    Three pressurized metered-dose inhalers (pMDIs; QVAR, Ventolin Evohaler, and Flovent HFA) were examined considering the joint effects of insertion angle (as above) and relative humidity at low (15%-25%) and high (>95%) conditions...When oriented toward the back of the oral cavity, the filter dose decreased from 46.5% to 36.9% for Ventolin Evohaler (p = 0.005) and from 56.7% to 44.2% for Flovent HFA (p < 0.001) at high humidity relative to low. High humidity may cause a reduction in total in vitro lung doses for some pMDI aerosols.
  • ||||||||||  budesonide / Generic mfg., Budenofalk (budesonide effervescent tablet) / Dr Falk
    Review, Journal:  Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. (Pubmed Central) -  Jun 23, 2020   
    The new orodispersible budesonide tablet with effervescent properties is the first approved esophageal-targeted formulation specifically developed for the treatment of EoE, which has become available in many European countries. This article gives an overview of the evolution of topical corticosteroids in EoE and provides an update on recent data from large-scale multicenter trials exploring the efficacy and safety of the orodispersible budesonide tablet with effervescent properties in adult EoE patients.
  • ||||||||||  methylprednisolone oral / Generic mfg., budesonide / Generic mfg.
    Clinical, Journal:  Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps. (Pubmed Central) -  Jun 23, 2020   
    Budesonide suspension nasal drop can significantly improve the quality of life and reduce the endoscopic score following short-course treatment, and the treatment effect of nasal drop was better than that of regular nasal spray. Budesonide nasal suspension can be used as a regular treatment for eosinophilic CRSwNP and can be an alternative choice for patients with a high percentage of tissue eosinophil infiltration who cannot use oral glucocorticoids.
  • ||||||||||  Formoterol Clickhaler (formoterol dry-powder inhaler) / Vectura, Foradil Aerolizer (formoterol dry powder inhaler) / Novartis, budesonide / Generic mfg.
    Journal:  Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design. (Pubmed Central) -  Jun 19, 2020   
    Daily data will be captured for fractional exhaled nitric oxide, spirometry, asthma symptoms and medication use using devices connected to a smartphone via the STIFLE application. STIFLE will thereby enable not only characterisation of the variability of airway inflammation and clinical outcomes in relation to asthma worsening, but also elucidate the effect of as-needed budesonide/formoterol on airway inflammation against a background of daily maintenance therapy.
  • ||||||||||  budesonide / Generic mfg.
    Journal:  Latest developments on topical therapies in chronic rhinosinusitis. (Pubmed Central) -  Jun 18, 2020   
    Wide surgical access and aggressive surgical debridement of polyposis facilitates the delivery of steroid irrigations to sinonasal mucosa and is associated with improved long-term outcomes following endoscopic sinus surgery. The use of novel treatments remains within the research setting alone.
  • ||||||||||  budesonide / Generic mfg.
    Biomarker, Clinical, Journal:  Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma. (Pubmed Central) -  Jun 8, 2020   
    The rs12930749 effect was attenuated with budesonide (P =1.32E-02) and nedocromil (P =1.09E-02). Pharmacogenomic analysis revealed differential effects with placebo and drug treatment that could potentially guide precision drug development in asthma.
  • ||||||||||  budesonide / Generic mfg.
    Review, Journal:  Proline Metabolism in Tumor Growth and Metastatic Progression. (Pubmed Central) -  Jun 6, 2020   
    Specifically, we propose a model whereby proline availability generates a cycle based on collagen synthesis and degradation, which, in turn, influences the epigenetic landscape and tumor heterogeneity. Therapeutic strategies targeting this metabolic-epigenetic axis hold great promise for the treatment of metastatic cancers.
  • ||||||||||  sildenafil / Generic mfg., budesonide / Generic mfg.
    Journal:  Protein-Losing Enteropathy Following Fontan Palliation. (Pubmed Central) -  May 29, 2020   
    PLE mortality is high-approximately 50%-but may be mitigated by aggressive investigation and management. The evolving understanding of the role of lymphatics in the pathophysiology of PLE and the emerging role of interventional lymphatic procedures may further improve outcomes in this patient population.
  • ||||||||||  Veramyst (fluticasone furoate nasal spray) / GSK
    Preclinical, Journal:  Pulmonary dissolution of poorly soluble compounds studied in an ex vivo rat lung model. (Pubmed Central) -  May 28, 2020   
    A wetting factor was introduced to the in silico model to explain the difference in absorption profiles between the suspensions and dry powders, where AZD5423 had the poorest wettability, followed by FP and FF. The IPL model in combination with an in silico model is a useful tool for investigating pulmonary dissolution and improving understanding of dissolution-related parameters for poorly soluble inhaled compounds.
  • ||||||||||  budesonide / Generic mfg.
    Journal, Adverse events:  Adverse events related to low dose corticosteroids in autoimmune hepatitis. (Pubmed Central) -  May 26, 2020   
    The IPL model in combination with an in silico model is a useful tool for investigating pulmonary dissolution and improving understanding of dissolution-related parameters for poorly soluble inhaled compounds. Even low doses of corticosteroids frequently lead to substantial adverse events refuting the assumption that adverse events are prevented by administering low doses.
  • ||||||||||  Fasenra (benralizumab) / AstraZeneca
    [VIRTUAL] Benralizumab therapy in eosinophilic esophagitis () -  May 19, 2020 - Abstract #EAACI2020EAACI_2158;    
    More than 100 eosinophils per high-power fieldin the esophageal biopsies, that did not decrease with esomeprazole 80mg daily for 8 weeks. -Skin prick tests with aeroallergens, plant panallergens and foods: positives to lipid transfer protein, hazelnut, rice, corn, wheat, soy, egg and milk.
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD)
    [VIRTUAL] Evaluation and management of a clinic case: Corticosteroids hypersensitivity () -  May 19, 2020 - Abstract #EAACI2020EAACI_2139;    
    The immediate and delayed reading prick test, intradermal test and patch tests do not appear useful to confirm or exclude hypersensitivity to corticosteroids. The test of tolerance/exposure is essential for diagnosis of hypersensitivity to corticosteroids.In this case the latency between exposure and showing of acute reaction symptoms do not appear IgE- and T-cell-mediated.Finally it seems to be possible to confirm a high possibility of cross reactivity between different molecules of corticosteroids.
  • ||||||||||  Emerade  (epinephrine) / Bausch Health, budesonide / Generic mfg.
    [VIRTUAL] Cold urticaria – case report () -  May 19, 2020 - Abstract #EAACI2020EAACI_2107;    
    She had asthma controlled with inhaled budesonide/formoterol; no family history of allergic, immunologic diseases and/or chronic urticaria...Patients need to be counseled to avoid a prolonged skin contact with cold. The first-line symptomatic treatment is a nonsedating H1 antihistamine and an epinephrine autoinjector should be prescribed for severe reactions.